The Center for Innovative Minimally Invasive Therapy (CIMIT) announces that faculty research awards of up to $75,000 in direct costs are available for studies that explore new technologies or concepts in the area of minimally invasive therapy and diagnosis.
CIMIT was pioneered by its director, Professor John Parrish of Harvard Medical School and the Harvard-MIT Division of Health Sciences Technology, and is a consortium of MIT, the Massachusetts General Hospital, Brigham and Women's Hospital and Draper Laboratories.
"I see biomedical opportunities for MIT's technological skills and resources as a most promising area for expanding our impact on the national agenda. Our many research collaborations with MGH and other Partners HealthCare institutions have been fruitful and support our educational mission as well as our research and development ambitions," said President Charles M. Vest.
HST is working on several fronts to provide opportunities for MIT faculty to learn more about medical challenges being addressed by CIMIT and how they might participate in addressing those problems. CIMIT has identified five clinical focus areas around which to organize promising projects and drive its research agenda: cardiovascular disease, cancer, stroke, trauma and critical care, and new initiatives.
MIT faculty members at the level of instructor, research scientist or higher are eligible to apply as principal investigators. The deadline for preliminary applications is May 31; full applications are due June 30 and proposals are due July 30.
For more information, contact Professor Martha Gray, HST co-director, at mgray@mit.edu or Melissa Cohen at mcohen4@partners.org.
A version of this article appeared in the May 12, 1999 issue of MIT Tech Talk (Volume 43, Number 30).
